Broadly neutralizing antibodies, or bnAbs, are a long‑standing goal of HIV vaccine research because they can disable many strains of the virus at once.
Researchers have developed a GPS vaccine that guides the immune system to create broadly neutralizing antibodies against HIV. For many years, researchers have been trying to develop an HIV vaccine ...
Discovery brings us one step closer to vaccine and treatment for prevalent virus. Image courtesy of the Centers for Disease Control. Scientists at The University of Texas at Austin, in collaboration ...
LA JOLLA, CA and NEW YORK, NY—A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce antibodies that can target many variants of ...
The need for more effective protection against influenza continues to grow, as the virus consistently causes significant ...
A study has found that repeat vaccination with updated versions of the COVID-19 vaccine promotes the development of antibodies that neutralize a wide range of variants of the virus that causes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results